Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

94.73
Delayed Data
As of 4:00pm ET
 -1.13 / -1.18%
Today’s Change
49.40
Today|||52-Week Range
153.99
-25.44%
Year-to-Date

Today’s Trading

Previous close95.86
Today’s open96.19
Day’s range94.48 - 97.15
Volume948,933
Average volume (3 months)994,499
Market cap$13.3B
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)-13.15%
Earnings growth (this year)-25.30%
Earnings growth (next 5 years)+163.00%
Revenue growth (last year)+90.66%
P/E ratioNM
Price/Sales127.96
Price/Book7.51

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-0.81-1.79%
SGENSeattle Genetics Inc-1.02-2.05%
TSROTESARO Inc+1.04+2.00%
JAZZJazz Pharmaceuticals...-1.13-0.73%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$1.31
Annual revenue (last year)$89.9M
Annual profit (last year)-$490.9M
Net profit margin-545.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts